Chargement en cours...
Gemcitabine nanoparticles promote antitumor immunity against melanoma
Myeloid-derived suppressor cells (MDSCs) promote tumor-mediated immunosuppression and cancer progression. Gemcitabine (Gem) is a MDSC-depleting chemotherapeutic agent; however, its clinical use is hampered by its drug resistance and inefficient in vivo delivery. Here we describe a strategy to formul...
Enregistré dans:
| Publié dans: | Biomaterials |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281175/ https://ncbi.nlm.nih.gov/pubmed/30388589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2018.10.022 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|